Becton Dickinson and Company (BDX)

76.42 -0.43  -0.56%  Feb 10, 11:00PM Go Pro
Watch
View Full Chart BDX Price Chart

Key Stats

Market Cap 16.32B
Revenue Growth 2.48%
Profit Margin 13.93%
Earnings Yield 7.16%
Dividend Yield 2.30%
Earnings Per Share TTM 5.47
PE Ratio 13.97
Price / Sales Ratio 2.07
52 Week High 89.75
52 Week Low 69.59
Beta 0.59
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

Feb 10 Becton Dickinson Still A Fine Specimen
Feb 10 How Taxes Diminish Long Term Returns For Investors In High Yield Stocks
Feb 10 U.S. Companies Issuing Profit Outlooks for the Week of Feb. 10
Feb 10 BD to Present at Investor Healthcare Conferences PR Newswire
Feb 10 What Becton, Dickinson Does With Its Cash Fool
Feb 10 BECTON DICKINSON & CO Financials
Feb 10 Notable Put Options Activity in Becton, Dickinson and Company Benzinga
Feb 09 [video] When Will Apple Pay Dividends? MarketWatch
Feb 09 Stockpickrs 19 Dividend Opportunity Stocks
Feb 09 8 Strong Growth & Value Stocks Selling At 52 Week Lows
Feb 08 Medical devices are such a tough biz these days. Just look at that $BDX report. Unlike biotech/pharma, payers are really pressuring margins. by bradloncar
Feb 07 Remembrance of Buy List Stocks Past | via @EddyElfenbein http://stks.co/2I75 $GILD $LUK $JEF $DLX $BDX $ABT by STNet
Feb 07 $BDX filed latest Quarterly Report http://stks.co/2Hm9 by MarketBrief
Feb 07 Listen to $BDX Q1 2012 earnings call (EPS 1.21 vs est 1.17) - live at 08:00 AM, ondemand after - http://stks.co/2HJg by earningscast
Jan 31 Listen to $BDX Becton, Dickinson and Company Shareholders Meeting - live at 01:00 PM, ondemand after - http://stks.co/2AlD by earningscast

Profile

Exchange: NYSE       Sector: Healthcare       Industry: Medical Instruments & Supplies

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Becton Dickinson and Company is down N/A over the last year vs S&P 500 Total Return up N/A, Baxter International up N/A, and C. R. Bard down N/A.

  • BDX Total Returns
  • ^SPXTR Total Returns
  • BAX Total Returns
  • BCR Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring BDX

Did Becton Dickinson and Company make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

BDX Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
BDX 76.42 -0.43 -0.56% 16.32B
SFL 11.65 -0.37 -3.08% 921.86M
BCO 24.17 0.04 0.17% 1.13B
SRZ 7.77 -0.11 -1.40% 447.79M
XFN 0.49 0.04 7.72% 10.35M
TGH 30.98 -0.55 -1.74% 1.52B
AMX 23.83 -0.70 -2.85% 96.03B
NRT 32.70 -0.30 -0.91% 300.51M
DOM 10.40 -0.18 -1.67% 81.64M
MSB 31.14 -0.57 -1.80% 408.56M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close